Skeletal muscle adaptation

"Skeletal muscle adaptation" is not a single molecule, receptor, or canonical drug target. Instead, it refers to the broad physiological and molecular processes by which skeletal muscle tissue responds to various stimuli—most notably exercise, inactivity, aging, or disease. These adaptations include changes in muscle fiber size (hypertrophy or atrophy), metabolic enzyme expression, mitochondrial content, contractile protein composition, and signaling pathway activity. Key molecular pathways involved in skeletal muscle adaptation include the PI3K-AKT-FoxO axis for growth/atrophy balance; MAPK signaling for stress response; AMPK for energy sensing; Ca2+/calmodulin-dependent kinases; calcineurin/NFAT pathway for fiber-type specification; and transcriptional regulators such as PGC1α[2][5][6]. Adaptations are highly specific to the type of stimulus—endurance training promotes mitochondrial biogenesis and oxidative metabolism while resistance training drives hypertrophy through increased protein synthesis[7][8]. The process is relevant in health maintenance across the lifespan as well as in prevention of chronic diseases like diabetes and cardiovascular disorders[9]. Because "skeletal muscle adaptation" describes a set of biological responses rather than a discrete molecular entity or therapeutic target (such as a receptor or enzyme), it does not have an official abbreviation nor does it fit into standard drug-target classification schemes. There are no direct drugs that "target" skeletal muscle adaptation itself—rather, interventions may modulate upstream pathways involved in these adaptive processes. In summary: "Skeletal muscle adaptation" is not a canonical molecule/receptor but rather an umbrella term describing complex physiological changes involving many molecules and pathways within skeletal muscles responding to external stimuli such as exercise or disuse[1][2][3].

Other names

Skeletal muscle plasticityMuscle adaptationSkeletal muscle remodeling